Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
Bohrmann B, Baumann K, Benz J, Gerber F, Huber W, Knoflach F, Messer J, Oroszlan K, Rauchenberger R, Richter WF, Rothe C, Urban M, Bardroff M, Winter M, Nordstedt C, Loetscher H.
Bohrmann B, et al. Among authors: messer j.
J Alzheimers Dis. 2012;28(1):49-69. doi: 10.3233/JAD-2011-110977.
J Alzheimers Dis. 2012.
PMID: 21955818